![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, October 10, 2007 11:38:55 AM
I didn't claim they "had to state" they weren't making any cures. The company said that voluntarily before the SEC got involved. Refer to the dates I posted.
RabiCide "cures" rabies? You mean the drug that even NNVC says doesn't work more than 30% of the time?
http://investorshub.advfn.com/boards/read_msg.asp?message_id=23085703
I really don't want my doctor giving me a drug that will help me 30% of the time, while the other 70% of the time I just die. Bad odds.
Oh, thanks for reminding us earlier today how many years it will take before any of their drugs get to market. If more solid information like that was posted here, perhaps the share price would stop falling.
How's the mythical manufacturing facility coming along?
Over a year ago in May 2006:
"The company also announced that it is actively seeking to build or acquire approximately 50,000 square feet of research and manufacturing space in the U.S."
http://www.pharmacychoice.com/news/article.cfm?Article_ID=27678
I guess your defintion of "active" is different than mine. Do you count the May 2006 press release as another "success story"?
But 90 years later, they've got that Spanish Flu licked!
Hype is a dangerous tool in the wrong hands.
Recent NNVC News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/09/2024 08:30:39 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/09/2024 08:05:25 PM
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM
Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM
Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM
POET Technologies Reports Second Quarter 2024 Financial Results • POET • Aug 15, 2024 8:04 AM